CONDITION
Hypothyroidism in Dogs
Hypothyroidism is a condition in which the thyroid gland produces less thyroid hormone than the body needs. Thyroid hormone influences metabolic rate in nearly every tissue, so when levels fall, many body systems tend to slow down. In dogs, the most common underlying cause is lymphocytic thyroiditis—an immune-mediated process in which the body's own immune cells gradually damage the thyroid tissue—though the gland can also be affected by atrophy of unknown cause, and rarely by other processes. Owners often notice a gradual change in energy, weight, coat quality, or behaviour. A dog may become less playful, gain weight despite no change in food, develop a dull or thinning coat, or seek out warm places more than before. Because the signs accumulate slowly and can be subtle, they are sometimes attributed to age or temperament, and the pattern may only become clear in hindsight. Certain breeds carry higher genetic risk, particularly through specific dog leukocyte antigen (DLA) haplotypes associated with autoimmune thyroiditis. This page explores what hypothyroidism can look like across different body systems, the mechanisms that lead to low thyroid hormone, how the condition is investigated through blood tests and clinical assessment, and the landscape of approaches used to restore thyroid hormone levels and support long-term metabolic health.
Why this matters now
Hypothyroidism tends to appear in middle-aged dogs, typically between four and ten years of age, though onset can occur earlier or later. Certain breeds show higher rates of occurrence, including Golden Retrievers, Dobermanns, Cocker Spaniels, and Miniature Schnauzers, suggesting a heritable component in some populations. The condition can also develop following thyroid surgery, radiation therapy to the neck region, or in association with other immune-mediated disorders. In many cases, the underlying process may be present for months or years before the changes in metabolism become noticeable to an owner.
The decline in thyroid hormone production often occurs gradually, with signs accumulating over months to years rather than appearing suddenly. Early metabolic shifts may be subtle and attributed to ageing or reduced activity, which can delay recognition. As hormone levels continue to fall, the effects on skin, coat, weight, and energy become more pronounced. The rate of progression varies considerably between individuals, influenced by the extent of gland destruction, the presence of any remaining functional tissue, and the metabolic demands placed on the body.
Signals & patterns
Early signals
Reduced energy and stamina
Dogs may appear less enthusiastic about walks, tire more quickly during play, or spend more time resting. The shift is often gradual, and owners sometimes interpret it as a natural part of growing older rather than a metabolic change.
Weight gain without diet change
Gradual accumulation of weight can occur even when food intake remains constant, reflecting a slower metabolic rate. The increase tends to be steady rather than sudden, and may be accompanied by a less defined body shape.
Coat texture and shedding changes
The coat may become dry, coarse, or brittle, and shedding can increase. Some dogs develop a patchy or uneven appearance, particularly over the back and flanks, where hair renewal slows.
Cold-seeking behaviour shifts
Dogs may seek out warmer spots in the house, lie closer to radiators, or seem less tolerant of cold weather. This reflects a reduced ability to generate and maintain body heat at the usual rate.
Later signals
Symmetrical hair loss
Patchy areas of hair loss often develop in a symmetrical pattern, typically sparing the head and legs. The skin underneath may appear thickened, darker, or slightly scaly, and regrowth is slow or absent without intervention.
Facial puffiness or drooping
Accumulation of mucin-like material in facial tissues can create a thickened, puffy, or 'tragic' expression, with drooping eyelids or jowls. This change reflects altered protein metabolism in the skin and subcutaneous layers.
Marked lethargy and mental dullness
Some dogs become notably slower to respond, less interested in their surroundings, or appear less alert. This can extend to training recall, social interaction, and general responsiveness to stimuli.
Click to read about the biological mechanisms
How this is usually investigated
The investigation of suspected hypothyroidism typically begins with a careful history and physical examination, establishing the pattern and duration of clinical signs. Because many of the features can overlap with other conditions or normal ageing, blood tests measuring thyroid hormone levels form the core of diagnostic evaluation. Additional tests may be performed to clarify equivocal results, to assess the functional impact of thyroid deficiency on other organ systems, or to identify concurrent conditions that can influence thyroid hormone measurements.
Total T4
Free T4 by equilibrium dialysis
Canine thyroid-stimulating hormone (cTSH)
Thyroglobulin autoantibody test
Complete blood count
Options & trade-offs
Management of hypothyroidism in dogs centres on thyroid hormone replacement, with the goal of restoring normal metabolic function and resolving clinical signs. The approach is individualised based on the dog's response to treatment, concurrent health conditions, and practical considerations around medication administration. Most dogs require lifelong therapy, with periodic adjustments to dosing as the dog ages, gains or loses weight, or develops other medical conditions.
Levothyroxine supplementation
Synthetic thyroxine (levothyroxine sodium) is administered orally, typically twice daily, to replace the deficient hormone. The dose is calculated based on body weight, then adjusted according to clinical response and follow-up thyroid hormone measurements performed 4 to 6 weeks after starting treatment or changing dose. Most dogs show improvement in energy and behaviour within a few weeks, whilst dermatological changes may take several months to resolve fully.
Trade-offs: Twice-daily dosing can be challenging for some households, though once-daily administration may be effective in certain dogs. Over-supplementation can produce signs of hyperthyroidism (restlessness, increased appetite, weight loss, panting), whilst under-supplementation leaves clinical signs unresolved; finding the appropriate dose requires patience and follow-up testing.
Monitoring and dose adjustment
Periodic measurement of thyroid hormone levels guides dose adjustments to maintain thyroid hormones within the target range. Blood samples are typically collected 4 to 6 hours after the morning dose to assess peak levels, though protocols vary. Clinical response (resolution of signs, body weight trends, coat quality) is evaluated alongside laboratory findings.
Trade-offs: The timing of blood sampling relative to tablet administration affects results, and consistency in timing between tests improves interpretation. Some dogs require more frequent monitoring than others, particularly during the initial stabilisation period or when intercurrent illness or other medications are introduced.
Dietary and weight management
Many hypothyroid dogs are overweight at diagnosis due to reduced metabolic rate and decreased activity. As thyroid hormone replacement restores normal metabolism, energy requirements often increase, and dietary intake may need adjustment to support gradual, controlled weight loss if obesity is present. Regular body condition assessment helps guide feeding decisions.
Trade-offs: Weight loss occurs slowly even with appropriate thyroid replacement, and some dogs may need concurrent caloric restriction to achieve a healthy body condition. Rapid dietary changes can be poorly tolerated, and weight management is most successful when approached gradually alongside normalisation of thyroid function.
Management of concurrent skin conditions
Secondary bacterial or yeast skin infections are common in hypothyroid dogs due to altered skin barrier function and sebaceous gland activity. Topical or systemic antimicrobial therapy may be needed whilst thyroid replacement is being established, as dermatological improvements lag behind metabolic normalisation. Some dogs benefit from medicated shampoos or other supportive skin care during the recovery phase.
Trade-offs: Skin lesions can take several months to resolve fully even with adequate thyroid replacement, and distinguishing between slow improvement and incomplete response requires time. Some dermatological signs may not resolve entirely if there is concurrent allergic or other skin disease unrelated to the thyroid deficiency.
Common misconceptions
"Hypothyroidism can be managed through diet alone without medication."
Hypothyroidism in dogs results from destruction or atrophy of thyroid tissue, meaning the gland cannot produce sufficient hormone regardless of nutritional intake. Whilst certain nutrients (such as iodine and selenium) are necessary for normal thyroid function, dietary manipulation cannot compensate for the absence of functional thyroid tissue, and hormone replacement is required to restore normal metabolism.
"Once the dose is established, no further monitoring is needed."
Thyroid hormone requirements can change over time due to alterations in body weight, the progression of thyroid gland destruction, the introduction of medications that affect thyroid hormone metabolism, or the development of concurrent illness. Periodic reassessment, typically every 6 to 12 months once stable, helps ensure the dose remains appropriate and that clinical signs remain well controlled.
"All overweight or lethargic dogs are hypothyroid."
Weight gain and reduced energy are common findings in many conditions and in normal ageing, and the majority of overweight or less active dogs do not have hypothyroidism. The diagnosis rests on a combination of compatible clinical signs, appropriate breed and age, and confirmatory thyroid hormone testing, not on the presence of weight gain or lethargy alone.
Related conditions
Obesity in Dogs
Hypothyroidism can contribute to weight gain and reduced metabolic rate, which may lead to obesity if food intake is not adjusted. Conversely, obesity itself can complicate the recognition of hypothyroidism, as lethargy and reduced activity may be attributed to excess weight rather than hormonal insufficiency.
Cushings Disease in Dogs
Cushing's disease and hypothyroidism can present with overlapping signs such as lethargy, weight changes, and coat abnormalities, which may complicate initial assessment. Both are endocrine disorders affecting metabolism, though they involve different glands and hormones.
Addisons Disease in Dogs
Addison's disease and hypothyroidism are both hormonal conditions that can cause non-specific signs including lethargy and weakness, and distinguishing between them often requires specific blood tests. In rare cases, dogs may have both conditions simultaneously, a scenario sometimes referred to as polyglandular autoimmune syndrome.
Diabetes Mellitus in Dogs
Hypothyroidism may alter insulin sensitivity and glucose metabolism in some dogs, though it does not typically cause diabetes mellitus directly. Both conditions affect metabolic regulation and may coexist in individual animals, particularly in breeds predisposed to endocrine disorders.
Atopic Dermatitis in Dogs
Hypothyroidism can contribute to skin changes including recurrent infections and altered coat quality, which may overlap with or exacerbate signs seen in atopic dermatitis. Some dogs with chronic skin conditions undergo thyroid testing as part of a broader investigation into underlying factors that influence skin health and immune function.
Hypothyroidism sits within a broader landscape of endocrine conditions that can affect metabolic health, and understanding how thyroid function interacts with other hormonal systems can provide useful context. For dogs on long-term medication, conversations around monitoring frequency, what to observe at home between checks, and how concurrent illness or new medications might influence thyroid requirements can be helpful. The Metabolic Health pillar explores related patterns in energy regulation, weight, and systemic function that may intersect with thyroid status.
Last reviewed: 24 April 2026 · Dr Alastair Greenway MRCVS